Superoxide has several sites of generation within cells, including mitochondria. Our studies with MitoSOX Red suggested that mitochondrial superoxide levels increased after RGC axotomy. To determine the source of the superoxide, we incubated RGCs for 1 hour and 24 hours in the presence of several inhibitors known to block endogenous ROS-generating systems and electron transfers in the mitochondria. Rotenone (1 μM), an inhibitor of complex I of the mitochondrial electron transport chain, did not prevent the increase in superoxide level—that is, levels at 1 hour and 24 hours were significantly different (0.96 ± 0.03 vs. 1.82 ± 0.10;
P < 0.0001). DPI (100 μM), a nonspecific inhibitor of NADPH oxidase and other flavoproteins, also proved ineffective in preventing the increase in superoxide levels (1.04 ± 0.04 vs. 1.99 ± 0.18;
P < 0.0001). Inhibition of cyclooxygenase with indomethacin (1 mM) and inhibition of xanthine oxidase with allopurinol (1 mM) similarly failed to prevent an increase in superoxide levels (1.02 ± 0.04 vs. 1.67 ± 0.12, 1.09 ± 0.04 vs. 1.66 ± 0.08, respectively;
P < 0.0001 for all comparisons). Only the inhibition of complex III of the electron transport chain with antimycin A (1 μM) successfully blocked the increase in superoxide level (0.80 ± 0.05 vs. 0.94 ± 0.08;
P = NS;
Fig. 5A ). The ability of a complex III inhibitor to prevent an oxidative burst after RGC axotomy was seen in 5 independent repetitions of the experiment and suggested that superoxide generation under these conditions was in the distal electron transport chain
(Fig. 5B) . Similar inhibition of superoxide production was seen with two other complex III inhibitors, stigmatellin and myxothiazol (which produce complex III inhibition at low concentrations and inhibit complex I and III at high concentrations). We found significant inhibition of RGC superoxide generation after dissociation with stigmatellin at 1 nM and myxothiazol at 1 μM (data not shown). Higher concentrations (3.2 μM and 10 μM) of myxothiazol led to increased generation of superoxide, consistent with the blocking of complex I. Finally, antimycin A caused decreased survival of some RGCs at 24 hours (28.2% ± 8.7% of control), as would be expected from a drug that blocks electron transport in mitochondria. To differentiate the effect of antimycin A inhibition on ROS generation from its effect on survival, we performed experiments in which we only imaged superoxide levels in live cells, as defined by their ability to exclude Sytox Green. We again found inhibition with antimycin A of superoxide generation induced by dissociation when live cells alone were imaged (data not shown). To control for any effects of antimycin A on the oxidation of HEt by superoxide, we performed a cell-free assay on a fluorescence plate reader using xanthine (1 mM) and xanthine oxidase (0.05 U/mL) in the presence of HEt (1 mM). Fluorescence readings after 30 minutes were not significantly different in the presence or absence (4546 ± 149 and 4574 ± 148, respectively;
P = NS) of antimycin A, even at 100 μM (4466 ± 66;
P = NS). Together, these studies suggest that complex III blockade inhibits superoxide generation in RGCs after axotomy.